John Skerritt, Theraputic Goods Administration - An update from the Medicines Regulator: Managing and Communicating Risk and Strengthening International Regulatory Convergence
Relevance and Challenges of Juvenile Toxicity Studies Can we? Should we? Will we? Diane Stannard Senior Study Manager Huntingdon Life Sciences 25 February.
>70
